Director/PDMR Shareholding

2022-11-22

Notification of Director / PDMR Dealing

The Board of DXS International plc (the “Company”), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems has received notification that on 18 November 2022 Mr David Immelman, the Chief Executive and DL Services Limited, a company owned and controlled by his wife, purchased a total of 50,084 Ordinary Shares in the Company at a price of 5.454p per share.

Following the transaction specified above Mr Immelman’s interests, including those of persons closely associated with him, is 5,770,585 Ordinary Shares representing 11.96% of the issued share capital of the Company.

Details of the person discharging managerial responsibilities / person closely associated a)

Name

David Immelman

2 Reason for the notification a)

Position/status

Chief Executiveb)

Initial notification /Amendment

Initial3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

DXS INTERNATIONAL PLCb)

LEI

2138001R1KEUWTXEVJ444

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a)

Description of the financial instrument, type of instrument Ordinary Shares of 0.33p each Identification code ISIN GB00B2Q6HZ92 b)

Nature of the transaction

Purchasec)

Price(s) and volume(s) Price(s)Volume(s) 5.454p50,084 d)

Aggregated information - Aggregated volume - Price e)

Date of the transaction

18 November 2022f)

Place of the transaction

AQSE The Directors of DXS International plc accept responsibility for this announcement

Enquiries:

David Immelman (Chief Executive)

DXS International plc01252 719800

david@dxs-systems.comWrecclesham House

Wrecclesham Road

Farnham

Surrey

GU10 4PS www.dxs-systems.co.uk

Corporate Advisor

David Papworth

City & Merchant0207 101 7676

Corporate Broker

Hybridan LLP

Claire Louise Noyce

020 3764 2341

Note to Editors:

DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively which should significantly contribute towards the NHS achieving its projected efficiency savings.

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构